Michael Dorry, MD, Duke Cancer Institute, is one of five 2019-2020 recipients of the Lung Cancer Initiative Research Grant. Grantees receive $25,000 and are selected based on the measurable impact of their proposal and commitment to the lung cancer field.
“We are pleased to support Dr. Dorry and the team at Duke and applaud their commitment to leading-edge research that will ultimately impact the future of cancer care,” said Paige Humble, executive director of the Lung Cancer Initiative of North Carolina.
The purpose of the LCI Research Grant Program is to partner with leading cancer centers to foster important research in their own communities and encourage researchers to enter the field. Many LCI grant recipients have gone on to receive continued funding for their work from the National Institutes of Health, Department of Defense and American Cancer Society.
“It is a privilege to receive this award. By partnering with Duke Interventional Pulmonology and the Duke Cancer Institute, we will be able to leverage all of the innovation and resources available to conduct our research to improve the care of patients with lung cancer,” said Dr. Dorry.
Lung cancer claims more lives annually in the United States than any other cancer and more than breast, colon and prostate cancers combined, yet it is greatly underfunded. Since 2008, the Lung Cancer Initiative has funded more than $1.7 million toward lung cancer research.
The Lung Cancer Inititative of North Carolina will host its 13th annual LUNGe Forward 5K on Sunday, Sept. 29, at 12:30 p.m. at Midtown Park at North Hills in Raleigh, North Carolina. Team Duke Cancer Institute will be led for a second year by Jeffrey Clarke, MD, a medical oncologist specializing in cancers of the chest, including lung cancer and mesothelioma. To join or support the team, visit Team Duke Cancer Institute.